“Microplastics in the human body disrupt hormones and reduce fertility.”

• Microplastic and nanoplastic particles have been documented inside human tissues and fluids, including blood (Leslie et al., Environment International 2022), placenta (Ragusa et al., 'Plasticenta', 2021), arterial plaque (Marfella et al., NEJM 2024), and brain tissue (Nihart et al., Nature Medicine 2025) — establishing that internal human exposure is real and widespread, a prerequisite for the claim.
• Studies published in 2023–2024 reported microplastics in human semen, testes, and ovarian follicular fluid, and some found inverse associations between particle concentrations and sperm concentration/motility — consistent with (though not proof of) a reproductive effect.
• Plastics carry and leach well-established endocrine-disrupting chemicals — bisphenols, phthalates, alkylphenols, certain flame retardants and PFAS. Human epidemiology and the Endocrine Society's EDC-2 scientific statement link these to altered sex-hormone levels, reduced semen quality, anogenital distance changes in boys, and reduced fecundability. Microplastics act as a vector for these compounds.
• Rodent and in vitro studies consistently show that polystyrene micro/nanoplastics can cross the blood–testis and placental barriers, induce oxidative stress and inflammation in gonads, lower testosterone, disrupt spermatogenesis, and reduce oocyte quality at the doses tested.
• Global declines in sperm counts (Levine et al. meta-analyses) coincide with the plastics era, and many researchers consider plastic-associated chemical exposure a plausible contributing driver.
• Multiple national and international bodies (WHO, NIEHS, EU/EFSA) have flagged micro- and nanoplastics as an emerging concern requiring urgent research into reproductive and endocrine endpoints.

• No study has demonstrated that microplastic particles themselves cause hormone disruption or infertility in humans. Human data are cross-sectional and correlational; reverse causation and confounding (smoking, obesity, diet, co-exposures) are not excluded.
• WHO's assessments of microplastics in drinking water (2019) and its 2022 follow-up concluded the evidence base is limited and of low quality, with no confirmed human health hazard established at current exposure levels — explicitly calling the risk assessment inconclusive rather than demonstrated.
• The strongest endocrine-disruption evidence concerns plastic-associated chemicals (phthalates, BPA), not the plastic particles. The claim conflates 'microplastics' with the chemical additives, which have separate exposure pathways (diet, personal care products) and separate regulatory handling.
• Animal studies showing reproductive harm typically use doses and particle types (uniform virgin polystyrene spheres, often mg/kg/day) far above and chemically unlike realistic human environmental exposures; extrapolation is contested.
• Methodological problems plague the field: airborne plastic contamination of lab samples, inconsistent detection methods (µFTIR, Raman, Py-GC/MS), and lack of standardized quantification have produced results varying by orders of magnitude. Several high-profile estimates (e.g., 'a credit card a week') have been criticized as unreliable.
• Population-level fertility outcomes are driven overwhelmingly by social and behavioral factors; no study has quantified any attributable fraction of human infertility to microplastics. The claim's flat assertion of 'reduce fertility' states as settled fact what researchers describe as a hypothesis under investigation.

76/100 — the lab’s own confidence in the score above, not a second reading of the claim.

Environment International (Leslie et al., 2022) — microplastics in human bloodjournal · 90 · Environment International (Ragusa et al., 2021) — 'Plasticenta': microplastics in human placentajournal · 88 · New England Journal of Medicine (Marfella et al., 2024) — micro/nanoplastics in atheromasjournal · 95 · Nature Medicine (Nihart et al., 2025) — bioaccumulation of microplastics in human brain tissuejournal · 90 · Endocrine Reviews — EDC-2: Endocrine Society Scientific Statement on endocrine-disrupting chemicalsjournal · 93 · US National Institute of Environmental Health Sciences — Endocrine Disruptorsgov · 92 · World Health Organization — Dietary and inhalation exposure to nano- and microplastics and potential implications for human health (2022)gov · 92 · World Health Organization — Microplastics in drinking-water (2019)gov · 90

• Microplastics have been detected in human blood, placenta, and reproductive tissue, so internal exposure is real rather than hypothetical; however, detection alone does not prove harm.
• A 2024 Toxicological Sciences study found microplastics in human and dog testes; in dogs, higher PVC levels were negatively associated with testis weight and sperm count, which is suggestive but not direct proof of reduced human fertility.
• Many plastics contain or carry endocrine-active chemicals such as phthalates and bisphenol A; major endocrine reviews and NIEHS identify these chemicals as capable of interfering with hormone signaling and reproductive biology.
• Reviews of microplastics note plausible mechanisms for endocrine/reproductive effects, including leaching of additives, adsorption of pollutants, oxidative stress, and inflammation; animal and cell studies are more supportive than human studies.

• The claim is phrased as established human causation, but human evidence that microplastics in the body actually disrupt hormones or reduce fertility is still limited and not definitive.
• WHO’s 2022 review concluded that evidence on human health risks from micro- and nanoplastic exposure remains insufficient, with major gaps in exposure, toxicology, and epidemiology.
• EFSA similarly found that data on microplastics/nanoplastics in food and their toxicity were too limited for a full human risk assessment.
• Human detection studies in blood, placenta, and testes are generally small or exploratory and mostly show presence, not endocrine disruption or infertility outcomes.
• Much of the stronger fertility/hormone evidence concerns plastic additives such as phthalates and BPA, not necessarily microplastic particles themselves; treating these as the same thing overstates the evidence.

78/100 — the lab’s own confidence in the score above, not a second reading of the claim.

World Health Organizationgov · 95 · European Food Safety Authoritygov · 93 · Environment Internationaljournal · 88 · Environment Internationaljournal · 86 · Toxicological Sciencesjournal · 86 · Endocrine Reviewsjournal · 91 · National Institute of Environmental Health Sciencesgov · 92 · International Journal of Environmental Research and Public Healthjournal · 74

• Microplastics act as carriers for Endocrine Disrupting Chemicals (EDCs) such as bisphenols (like BPA), phthalates, and PFAS. These chemicals are extensively proven to interfere with human hormonal systems and negatively impact reproductive health.
• Recent peer-reviewed studies have successfully detected microplastics and nanoplastics in human blood, placentas, breast milk, and testicular tissue, proving that these particles can cross biological barriers and accumulate in reproductive organs.
• Numerous in vivo and in vitro animal models (e.g., mice) have demonstrated that exposure to microplastics causes reproductive toxicity, leading to decreased sperm count and viability, disrupted testosterone production, and impaired ovarian function.

• While animal models and cellular in vitro studies show clear negative effects, direct longitudinal epidemiological data definitively proving that microplastic particles cause clinical infertility in humans—isolated from other environmental, genetic, and lifestyle factors—is still emerging.
• The exact threshold at which the concentration of physical microplastic particles in the human body becomes toxic to reproductive health remains an active subject of toxicological research.
• Scientists are still determining the extent to which hormonal disruption is caused by the physical microplastic particles themselves versus the chemical additives leaching from them, though both are inextricably linked in real-world exposure.

90/100 — the lab’s own confidence in the score above, not a second reading of the claim.

National Institute of Environmental Health Sciences (NIEHS)gov · 95 · Naturejournal · 95

• Microplastics have been detected in human semen, and one study found lower progressive sperm motility among participants with PET microplastics; however, it found no significant association with sperm concentration or total sperm count and called for larger studies.[5]
• Experimental studies in female animals generally report altered hormone levels, ovarian effects, and reduced fertility, but these findings do not establish equivalent effects in humans.[6][9]
• Laboratory exposure of human sperm to high concentrations of PVC microplastics reduced motility and increased oxidative stress and DNA damage; this was an in-vitro study, so it does not demonstrate effects from ordinary human exposure.[3]
• A 2025 review of female-reproductive experiments reported effects on ovarian function, fertility, and hormones, while also noting variable study quality and a high risk of bias in some studies.[9]

• Human evidence remains limited and does not establish that microplastics cause hormonal disruption or infertility. The human semen study found no significant association with sperm concentration or total sperm count and explicitly said larger studies are needed.[5]
• The strongest hormone evidence in the retrieved sources comes from animal experiments, particularly studies of the hypothalamus-pituitary-ovary axis, rather than controlled human studies.[6]
• The striking human-sperm laboratory findings used PVC concentrations up to 400 micrograms per milliliter for six hours, conditions that may not represent typical internal human exposure.[3]
• Associations between microplastic detection and reproductive measures can be affected by confounding, exposure-measurement limitations, contamination, and uncertainty about dose; the available evidence does not demonstrate reduced fertility at the population level.

86/100 — the lab’s own confidence in the score above, not a second reading of the claim.

PubMed; peer-reviewed human semen studyjournal · 94 · Human Reproduction; peer-reviewed conference abstractjournal · 82 · PubMed; systematic review of animal studiesjournal · 92 · PubMed; systematic review of experimental studiesjournal · 91 · Human Reproduction; systematic narrative review abstractjournal · 78

• Microplastics have been detected in human blood, placenta, lungs, testes and semen.
• Common plastic additives (BPA, phthalates) are established endocrine-disrupting chemicals that interfere with hormone receptors and steroidogenesis.
• Rodent and in-vitro studies show microplastic exposure can lower testosterone, impair spermatogenesis, reduce ovarian follicles and alter reproductive hormone levels.
• Some observational human data link higher internal plastic-associated chemical levels with poorer semen quality.

• No adequately powered human epidemiological studies have demonstrated that the particle burden itself (versus co-occurring chemicals or confounders) causes clinical hormone disruption or reduced fertility.
• Toxicology data are dominated by animal models using doses far above estimated human exposures.
• WHO assessments of microplastics in drinking water found insufficient evidence of health risk and called for more research.
• Effects, when observed, may be driven by leachable additives rather than the polymer particles named in the claim.

68/100 — the lab’s own confidence in the score above, not a second reading of the claim.

Environment Internationaljournal · 92 · Environment Internationaljournal · 92 · NIEHS/NIHgov · 95 · World Health Organizationother · 93